The following table sets forth the computation of the basic and diluted net loss per share for the three months ended March 31, 2024 and 2023 (in thousands, except share and per share data):


	Three Months Ended March 31,
	2024			2023
Numerator:
Net loss	$	(30,521	)	$	(29,271	)
Denominator:
Weighted-average shares used to compute net loss per share, basic and diluted		38,625,365			38,280,539
Net loss per share, basic and diluted	$	(0.79	)	$	(0.76	)

For the three months ended March 31, 2024 and 2023, 4,000,000 pre-funded warrants to purchase the Company’s shares of common stock, issued in the May 2022 private placement financing, were included on a weighted average basis in the basic and diluted net loss per share calculation. As of March 31, 2024, all the pre-funded warrants issued in the private placement financing were outstanding.

Potential dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:


	As of March 31,
	2024		2023
Stock options issued and outstanding under the 2019 Plan and 2015 Stock Plan		5,484,490		3,786,831
Estimated shares issuable under the 2019 ESPP		61,848		46,101
RSUs subject to future vesting		—		13,500
Total		5,546,338		3,846,432